Suchergebnisse - "Chakraborty, Sweta"

PubPharm (11)

1

The future of risk communication and the role of the pharmaceutical industry

enthalten in: Current drug safety | 2013

von Chakraborty, S. | Bouder, F.

2

Transparency and the Food and Drug Administration--a quantitative study

enthalten in: Journal of health communication | 2013

von Lofstedt, R. | Bouder, F. | Chakraborty, S.

3

The Future of Risk Communication and the Role of the Pharmaceutical Industry

enthalten in: Current drug safety | 2013

von Chakraborty, S. | Bouder, F.

4

Risk Communication and the Pharmaceutical Industry : what is the reality?

enthalten in: Drug safety | 2012

von Edwards, B. | Chakraborty, S.

5

Risk Communication and the Pharmaceutical Industry

enthalten in: Drug safety | 2012

von Edwards, B. | Chakraborty, S.

6

Transparency Initiative by the FDA's Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions

Erschienen: 2012

von Chakraborty, S. | Lofstedt, R.

7

The Role of Communication in Promoting a European Wide Approach to Risk Based Regulation

Erschienen: 2012

von Chakraborty, S.

8

Initial Phase Crisis Communications Following High Perceived Risk Events: The Volcanic Ash Crisis and the Japanese Tsunami as Examples

Erschienen: 2011

von Chakraborty, S. | Creutzfeldt-Banda, N.

9

Regulatory Transparency: Forthcoming Lessons from the FDA

Erschienen: 2010

von Chakraborty, S. | Lofstedt, R.

10

Implications of the Risk Communication Guidelines for the European Union

Erschienen: 2010

von Chakraborty, S. | Creutzfeldt-Banda, N.